Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBXO21 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF576 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | USPL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LEPROT | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RP1-27O5.3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-12J10.3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF511 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SMPD4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GGA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |